Related Experiment Video
Updated: Jul 4, 2026
09:06
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNAs in normal and malignant hematopoiesis
1Division of Hematology and Oncology, Department of Medicine, The Ohio State University, Columbus, Ohio 43210, USA.
Current Opinion in Hematology
|June 10, 2008
Summary
MicroRNAs (miRNAs) are crucial regulators in blood cell development and function. Deregulation of these small RNAs is implicated in the development and progression of leukemia.
Area of Science:
- Genetics
- Molecular Biology
- Hematology
Background:
- MicroRNAs (miRNAs) have emerged as critical regulators in human genetics.
- Recent research has elucidated their significant roles in hematopoietic differentiation and leukemogenesis.
Purpose of the Study:
- To review the role of microRNAs in hematopoiesis, focusing on differentiation, proliferation, and immune function.
- To explore the involvement of microRNAs in the pathogenesis of leukemias and lymphomas.
Main Methods:
- Analysis of animal models with altered expression of specific microRNAs (e.g., miR-150, miR-17~92, miR-155, miR-223).
- Examination of microRNA signatures in acute myeloid leukemia associated with cytogenetics and patient outcomes.
Main Results:
- MicroRNAs are essential for B-lymphocyte development, granulopoiesis, and immune function.
- Specific microRNA profiles correlate with cytogenetic abnormalities and prognosis in acute myeloid leukemia.
- MicroRNA deregulation is a common feature in leukemias and lymphomas.
Conclusions:
- MicroRNAs significantly modulate hematopoietic cell differentiation, proliferation, and immune activity.
- Evidence strongly supports a role for microRNAs in the pathogenesis of hematological malignancies.
- Targeting microRNAs presents a potential therapeutic avenue for leukemia and lymphoma treatment.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...